<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosgen</journal-id>
<journal-title-group>
<journal-title>PLOS Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7390</issn>
<issn pub-type="epub">1553-7404</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pgen.1007012</article-id>
<article-id pub-id-type="publisher-id">PGENETICS-D-17-00524</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Cancer detection and diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer detection and diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Colorectal cancer</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical genetics</subject><subj-group><subject>Genetic diseases</subject><subj-group><subject>Autosomal dominant diseases</subject><subj-group><subject>Hereditary nonpolyposis colorectal cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Human genetics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer risk factors</subject><subj-group><subject>Genetic causes of cancer</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA repair</subject><subj-group><subject>Mismatch repair</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA repair</subject><subj-group><subject>Mismatch repair</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Genetic anticipation in Swedish Lynch syndrome families</article-title>
<alt-title alt-title-type="running-head">Anticipation in Swedish Lynch syndrome families</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2978-1416</contrib-id>
<name name-style="western">
<surname>von Salomé</surname>
<given-names>Jenny</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Boonstra</surname>
<given-names>Philip S.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Karimi</surname>
<given-names>Masoud</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3951-9753</contrib-id>
<name name-style="western">
<surname>Silander</surname>
<given-names>Gustav</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Stenmark-Askmalm</surname>
<given-names>Marie</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Gebre-Medhin</surname>
<given-names>Samuel</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Aravidis</surname>
<given-names>Christos</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2717-1937</contrib-id>
<name name-style="western">
<surname>Nilbert</surname>
<given-names>Mef</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lindblom</surname>
<given-names>Annika</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9848-0468</contrib-id>
<name name-style="western">
<surname>Lagerstedt-Robinson</surname>
<given-names>Kristina</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Genetics, Karolinska University Hospital, Solna, Stockholm, Sweden</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Oncology, Radiumhemmet, Karolinska University Hospital, Solna, Stockholm, Sweden</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Radiation Sciences, Umeå University, Umeå, Sweden</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Oncology, Linköping University, Linköping, Sweden</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Department of Clinical Genetics, Office for Medical Services, Division of Laboratory Medicine, Lund, Sweden</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden</addr-line></aff>
<aff id="aff010"><label>10</label> <addr-line>Clinical Research Centre, Hvidovre Hospital, Copenhagen University, Hvidovre, Denmark</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Stella</surname>
<given-names>Alessandro</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Section of Medical Genetics, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">jenny.vonsalome@sll.se</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2017</year>
</pub-date>
<volume>13</volume>
<issue>10</issue>
<elocation-id>e1007012</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>3</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>von Salomé et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pgen.1007012"/>
<abstract>
<p>Among hereditary colorectal cancer predisposing syndromes, Lynch syndrome (LS) caused by mutations in DNA mismatch repair genes <italic>MLH1</italic>, <italic>MSH2</italic>, <italic>MSH6</italic> or <italic>PMS2</italic> is the most common. Patients with LS have an increased risk of early onset colon and endometrial cancer, but also other tumors that generally have an earlier onset compared to the general population. However, age at first primary cancer varies within families and genetic anticipation, i.e. decreasing age at onset in successive generations, has been suggested in LS. Anticipation is a well-known phenomenon in e.g neurodegenerative diseases and several reports have studied anticipation in heritable cancer. The purpose of this study is to determine whether anticipation can be shown in a nationwide cohort of Swedish LS families referred to the regional departments of clinical genetics in Lund, Stockholm, Linköping, Uppsala and Umeå between the years 1990–2013. We analyzed a homogenous group of mutation carriers, utilizing information from both affected and non-affected family members. In total, 239 families with a mismatch repair gene mutation (96 <italic>MLH1</italic> families, 90 <italic>MSH2</italic> families including one family with an <italic>EPCAM–MSH2</italic> deletion, 39 <italic>MSH6</italic> families, 12 <italic>PMS2</italic> families, and 2 <italic>MLH1+PMS2</italic> families) comprising 1028 at-risk carriers were identified among the Swedish LS families, of which 1003 mutation carriers had available follow-up information and could be included in the study. Using a normal random effects model (NREM) we estimate a 2.1 year decrease in age of diagnosis per generation. An alternative analysis using a mixed-effects Cox proportional hazards model (COX-R) estimates a hazard ratio of exp(0.171), or about 1.19, for age of diagnosis between consecutive generations. LS-associated gene-specific anticipation effects are evident for <italic>MSH2</italic> (2.6 years/generation for NREM and hazard ratio of 1.33 for COX-R) and <italic>PMS2</italic> (7.3 years/generation and hazard ratio of 1.86). The estimated anticipation effects for <italic>MLH1</italic> and <italic>MSH6</italic> are smaller.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Genetic anticipation is a phenomenon where symptoms of a hereditary disease appear at an earlier age and/or are more severe in successive generations. In genetic disorders such as Fragile X syndrome, Myotonic dystrophy type 1 and Huntington disease, anticipation is caused by the expansion of unstable trinucleotide repeats during meiosis. Anticipation is also reported to occur in some hereditary cancers though the underlying mechanism behind this observation is unknown. Several studies have investigated anticipation in Lynch syndrome, the most common hereditary colorectal cancer syndrome, yet there is a debate concerning whether anticipation occurs and what underlying mechanism there is. The objective of this project is to study if anticipation is part of the clinical picture in Swedish families with LS, with the long term goal to enable better prediction of age at onset in family members. Our results suggest that anticipation occurs in families with mutation in <italic>MSH2</italic> and <italic>PMS2</italic>, while the evidence is equivocal for <italic>MLH1</italic> and <italic>MSH6</italic>.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>The regional agreement on clinical research between the Stockholm County Council and Karolinska Institutet</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2978-1416</contrib-id>
<name name-style="western">
<surname>von Salomé</surname>
<given-names>Jenny Kristina</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>P30 CA046592</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Boonstra</surname>
<given-names>Philip S.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>JvS was was supported by the regional agreement on clinical research between the Stockholm County Council and Karolinska Institutet. PSB was supported by the National Institutes of Health [P30 CA046592]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2017-11-10</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>The data that supports the findings of this study are deposited at the Center of Molecular Medicine data repository at the Karolinska Institute. Due to patient confidentiality, the data are only available upon request from the Lindblom Group at <email xlink:type="simple">registrator@ki.se</email>.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Lynch syndrome (LS) is an autosomal dominant inherited syndrome that increases the risk of cancer, primarily in the colon, the rectum and the endometrial lining of the uterus, and to a lesser degree also in the stomach, the ovary, the hepatobiliary tract, the urinary tract, the small bowel and the brain [<xref ref-type="bibr" rid="pgen.1007012.ref001">1</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref002">2</xref>]. LS is one of the most common heritable cancer syndromes, accounting for up to 4% of the total colorectal cancer burden in Europe, where patients have up to 70% lifetime risk of developing colorectal or endometrial cancer at an early age [<xref ref-type="bibr" rid="pgen.1007012.ref001">1</xref>]. LS was formerly known as hereditary non-polyposis colorectal cancer (HNPCC), but when clinical criteria evolved to take into account not only colorectal cancer to identify families with LS [<xref ref-type="bibr" rid="pgen.1007012.ref003">3</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref004">4</xref>] the name Lynch Syndrome became generally accepted [<xref ref-type="bibr" rid="pgen.1007012.ref005">5</xref>]. Today the diagnosis LS is restricted to families with a known pathogenic germline mutation in one of the mismatch repair (MMR) genes <italic>MLH1</italic>, <italic>MSH2</italic>, <italic>MSH6</italic> and <italic>PMS2</italic> irrespective of family history [<xref ref-type="bibr" rid="pgen.1007012.ref006">6</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref007">7</xref>]. The MMR system corrects indels or mismatches in the DNA, and is evolutionary conserved from bacteria to human [<xref ref-type="bibr" rid="pgen.1007012.ref008">8</xref>]. In human the recognition of nucleotide mismatches is mediated by the protein heterodimers <italic>MSH2/MSH6</italic> or <italic>MSH2/MSH3</italic>, while the removal and resynthesis of nucleotides is mediated by <italic>MLH1/PMS2</italic> [<xref ref-type="bibr" rid="pgen.1007012.ref009">9</xref>].</p>
<p>LS is a heterogeneous disease with regard to tumor spectrum and age at onset [<xref ref-type="bibr" rid="pgen.1007012.ref010">10</xref>]. Part of this phenotypic variation has been linked to specific MMR gene mutation. For instance, <italic>MLH1</italic> mutation carriers are suggested to have a higher risk for colorectal cancer (CRC) and earlier age of onset, compared to <italic>MSH2</italic> and <italic>MSH6</italic> mutation carriers [<xref ref-type="bibr" rid="pgen.1007012.ref011">11</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref015">15</xref>]. In general, <italic>MSH6</italic> mutation carriers tend to have a later age of onset and lower penetrance for LS associated tumors, apart from endometrial cancer, compared to <italic>MLH1</italic> and <italic>MSH2</italic> mutation carriers [<xref ref-type="bibr" rid="pgen.1007012.ref016">16</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref020">20</xref>]. An older age of onset and a lower overall risk for CRC has also been suggested for <italic>PMS2</italic> mutation carriers [<xref ref-type="bibr" rid="pgen.1007012.ref021">21</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref022">22</xref>]. However, LS display phenotypic variation in age of onset also within families and between families with the same mutation [<xref ref-type="bibr" rid="pgen.1007012.ref023">23</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref025">25</xref>]. This variation is attributed to individual genetic differences modifying the effect of an inherited MMR mutation [<xref ref-type="bibr" rid="pgen.1007012.ref026">26</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref031">31</xref>]. Another factor proposed to influence age at onset is genetic anticipation, defined as progressive earlier onset and severity of disease in successive generations within a family. This phenomenon is closely related to the disease mechanisms in several genetic disorders, e.g the neurodegenerative diseases Fragile X syndrome, Myotonic dystrophy type 1 and Huntington disease, in which trinucleotide repeat expansion directly influence expressivity and penetrance of disease [<xref ref-type="bibr" rid="pgen.1007012.ref032">32</xref>]. Anticipation has also been observed in hereditary cancer for example familial melanoma, Li-Fraumeni syndrome, breast, ovarian and pancreatic cancer, and recently in the renal cell cancer syndromes von Hippel-Lindau and HLRCC (hereditary leiomyomatosis and renal cell cancer) [<xref ref-type="bibr" rid="pgen.1007012.ref033">33</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref039">39</xref>]. In LS, a progressive decrease of age at CRC onset was proposed already in 1925 when the syndrome was first described [<xref ref-type="bibr" rid="pgen.1007012.ref040">40</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref041">41</xref>]. However, it is complicated to estimate genetic anticipation and there are contradictory reports regarding its existence in LS, though the majority indicate anticipation [<xref ref-type="bibr" rid="pgen.1007012.ref042">42</xref>–<xref ref-type="bibr" rid="pgen.1007012.ref052">52</xref>]. Previous studies have applied various statistical methodologies, compiled different mutations and included subjects with LS associated mutations as well as subjects with only a clinical diagnosis. In light of these studies, we analyzed affected and unaffected mutation carriers in LS families throughout Sweden, to investigate signs of anticipation using two regression models with adjustment for potential confounders, including gene-specific effects.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<p>In Sweden, families with suspected LS are referred to the regional department of Clinical genetics in Umeå, Uppsala, Stockholm, Linköping, Göteborg or Lund, for counceling and genetic testing. Out of this population-based cohort, families identified with a LS-associated MMR mutation that received genetic counseling in Lund, Stockholm, Linköping, Uppsala or Umeå between January 1990 and December 2013 were enrolled in this study. This project was approved in accordance with the Swedish legislation of ethical permission (2003:469). All patients provided oral or written informed consent for genetic diagnostics as part of their routine clinical care. This anonymized genetic information may be used for research without further consent sought from the patients if approved by an ethical review board. Accordingly, this study was approved by the Regional ethical review board in Stockholm (dnr 2014/1320-31).</p>
<p>Patient and family cancer history was reported at the time of genetic counseling and cancer diagnoses were further confirmed from medical records or pathology reports. A total of 239 families with proven pathogenic MMR variants described in [<xref ref-type="bibr" rid="pgen.1007012.ref053">53</xref>] (96 <italic>MLH1</italic> families, 90 <italic>MSH2</italic> families including one <italic>EPCAM-</italic>deletion family, 39 <italic>MSH6</italic> families, 12 <italic>PMS2</italic> families, and 2 <italic>MLH1+PMS2</italic> families), comprising 1029 mutation carriers, were identified in the cohort. One individual whose parents were both mutation carriers was excluded. Additionally, the sex of 11 carriers was unknown, and the age at diagnosis for an additional 14 was missing. We excluded these 25 individuals, leaving 1003 at-risk carriers with available follow-up information and sufficient pathological and medical information to be included in the study. We grouped the <italic>EPCAM-</italic>deletion family within the <italic>MSH2</italic> families, as it is reported that a partly deleted <italic>EPCAM</italic> gene (located upstream of <italic>MSH2</italic>) cause LS through reducing the expression of <italic>MSH2</italic> in <italic>EPCAM</italic>-expressing tissues [<xref ref-type="bibr" rid="pgen.1007012.ref054">54</xref>]. For statistical modeling purposes, we counted two families with mutations in both <italic>MLH1</italic> and <italic>PMS2</italic> as having mutations in <italic>PMS2</italic> only (unreported auxiliary analyses that excluded these families altogether or counted them as <italic>MLH1</italic> showed that our findings are not sensitive to this decision). The follow-up period was defined as the time from birth until age at onset, and for individuals who were diagnosed with multiple Lynch-related cancers, age of onset was recorded as the time of first diagnosis. Our first analytic approach was the normal random effects model (NREM) proposed by Larsen et al. [<xref ref-type="bibr" rid="pgen.1007012.ref045">45</xref>], which has been used previously to test for anticipation in LS [<xref ref-type="bibr" rid="pgen.1007012.ref043">43</xref>] and <italic>BRCA</italic>-mutation related cancers [<xref ref-type="bibr" rid="pgen.1007012.ref055">55</xref>]. Let <italic>n</italic><sub><italic>i</italic></sub> denote the number of carriers in the <italic>i</italic>th family, <italic>i = 1</italic>, <italic>2</italic>, <italic>…</italic>, <italic>239</italic>, and let <italic>j = 1</italic>, <italic>2</italic>, <italic>…</italic>, <italic>n</italic><sub><italic>i</italic></sub> index the <italic>j</italic>th individual in family <italic>i</italic>. The NREM is given by
<disp-formula id="pgen.1007012.e001">
<alternatives>
<graphic id="pgen.1007012.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo>
</mml:math>
</alternatives>
<label>(1)</label>
</disp-formula>
where <italic>T</italic><sub><italic>ij</italic></sub> is the age of diagnosis in years for the <italic>j</italic>th member of family <italic>i</italic> (“person <italic>ij</italic>”), <italic>μ</italic><sub><italic>i</italic></sub> is the family-specific random intercept representing a typical age of diagnosis in the <italic>i</italic>th family, <italic>Z</italic><sub><italic>ij</italic></sub> is person <italic>ij</italic>’s generation (coded with respect to oldest observed generation in each family, as described in [<xref ref-type="bibr" rid="pgen.1007012.ref041">41</xref>] and <italic>γ</italic>, the parameter of interest, is the mean change in age of diagnosis between consecutive generations, i.e. the anticipation effect. In the NREM, anticipation is indicated if <italic>γ &lt; 0</italic>. Collectively the <italic>X</italic><sub><italic>ij</italic></sub> term represents any other covariate(s) of interest for person <italic>ij</italic>, the effect of which is given by <italic>β</italic>. The final term <italic>ε</italic><sub><italic>ij</italic></sub> is the residual error, assumed to be independently and normally distributed with mean zero and variance <italic>σ</italic><sup><italic>2</italic></sup>. For each person who was not diagnosed with a Lynch-associated cancer during the follow-up period, the likelihood contribution is given by the normal survivor function, that is, the probability of being cancer-free at the age of last follow-up. We assume that the censoring mechanism is independent of the time to cancer diagnosis.</p>
<p>Our second analytic approach, which is also a regression strategy, extends the Cox proportional hazards model that was used in [<xref ref-type="bibr" rid="pgen.1007012.ref056">56</xref>] to test for anticipation in lymphoproliferative tumors. Person <italic>ij</italic>’s hazard for cancer diagnosis at age <italic>t</italic> is modeled as:
<disp-formula id="pgen.1007012.e002">
<alternatives>
<graphic id="pgen.1007012.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:mi>λ</mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mo>)</mml:mo><mml:mi mathvariant="normal">exp</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover><mml:msub><mml:mrow><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>.</mml:mo>
</mml:math>
</alternatives>
<label>(2)</label>
</disp-formula></p>
<p>The function <italic>λ</italic><sub><italic>0</italic></sub><italic>(t)</italic> is the overall baseline hazard function. In Daugherty et al., the baseline hazard was assumed to be identical for all families, that is, <inline-formula id="pgen.1007012.e003"><alternatives><graphic id="pgen.1007012.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e003" xlink:type="simple"/><mml:math display="inline" id="M3"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula> was not included in the model and within-family correlations were accounted for by robust sandwich-type covariance estimates. Here we add a random family-level effect <inline-formula id="pgen.1007012.e004"><alternatives><graphic id="pgen.1007012.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e004" xlink:type="simple"/><mml:math display="inline" id="M4"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, similar to NREM, which makes the less restrictive assumption that all families’ baseline hazards are proportional to, rather than equal to, one another. We call this Cox model with family-level random effect COX-R. The remaining parameters are analogous to NREM. Specifically, <inline-formula id="pgen.1007012.e005"><alternatives><graphic id="pgen.1007012.e005g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e005" xlink:type="simple"/><mml:math display="inline" id="M5"><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:math></alternatives></inline-formula> gives the generational effect of anticipation as a log-hazard ratio, with <inline-formula id="pgen.1007012.e006"><alternatives><graphic id="pgen.1007012.e006g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e006" xlink:type="simple"/><mml:math display="inline" id="M6"><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover><mml:mo>&gt;</mml:mo><mml:mn>0</mml:mn></mml:math></alternatives></inline-formula> indicating anticipation, and <inline-formula id="pgen.1007012.e007"><alternatives><graphic id="pgen.1007012.e007g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e007" xlink:type="simple"/><mml:math display="inline" id="M7"><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:math></alternatives></inline-formula> is the log-hazard ratio(s) for all other covariates.</p>
<p>In addition to adjusting for sex, we also included mutational status in NREM and COX-R. In Eqs (<xref ref-type="disp-formula" rid="pgen.1007012.e001">1</xref>) and (<xref ref-type="disp-formula" rid="pgen.1007012.e002">2</xref>), let person <italic>ij</italic>’s length-4 vector of covariates be given by <italic>X</italic><sub><italic>ij</italic></sub> <italic>= {1[sex</italic><sub><italic>ij</italic></sub> <italic>=</italic> male], <italic>1</italic>[<italic>gene</italic><sub><italic>i</italic></sub> <italic>= MSH2]</italic>, <italic>1</italic>[<italic>gene</italic><sub><italic>i</italic></sub> <italic>= MSH6]</italic>, <italic>1</italic>[<italic>gene</italic><sub><italic>i</italic></sub> <italic>= PMS2]}</italic>, where <italic>1[y]</italic> is the indicator function, equal to 1 if <italic>y</italic> is true, sex<sub>ij</sub> is the sex of person <italic>ij</italic> and <italic>gene</italic><sub>i</sub> is the mutational status of family <italic>i</italic>. <italic>MLH1</italic> serves as the reference category.</p>
<p>We also investigated whether there were gene-specific effects of anticipation by substituting <italic>Z</italic><sub><italic>ij</italic></sub> in Eqs (<xref ref-type="disp-formula" rid="pgen.1007012.e001">1</xref>) and (<xref ref-type="disp-formula" rid="pgen.1007012.e002">2</xref>) with the four dimensional covariate vector.</p>
<disp-formula id="pgen.1007012.e008">
<alternatives>
<graphic id="pgen.1007012.e008g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e008" xlink:type="simple"/>
<mml:math display="block" id="M8">
<mml:mtable><mml:mtr><mml:mtd><mml:msubsup><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">*</mml:mi></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mo>{</mml:mo><mml:mn>1</mml:mn><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>M</mml:mi><mml:mi>L</mml:mi><mml:mi>H</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mo>]</mml:mo><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>H</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>]</mml:mo><mml:mo>,</mml:mo></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mi>H</mml:mi><mml:mn>6</mml:mn></mml:mrow><mml:mo>]</mml:mo><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>P</mml:mi><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>]</mml:mo><mml:mo>}</mml:mo><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable>
</mml:math>
</alternatives>
</disp-formula>
<p>All analysis was done in the R software package R Core Team [<xref ref-type="bibr" rid="pgen.1007012.ref057">57</xref>]. Code for maximizing the integrated partial likelihood of model (2), marginalized over the random effects <inline-formula id="pgen.1007012.e009"><alternatives><graphic id="pgen.1007012.e009g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e009" xlink:type="simple"/><mml:math display="inline" id="M9"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula>, is provided in the R package COXME [<xref ref-type="bibr" rid="pgen.1007012.ref058">58</xref>].</p>
</sec>
<sec id="sec003" sec-type="results">
<title>Results</title>
<p><xref ref-type="table" rid="pgen.1007012.t001">Table 1</xref> presents the clinical characteristics of our data and <xref ref-type="fig" rid="pgen.1007012.g001">Fig 1</xref> plots the Kaplan-Meier estimate of the time to first Lynch-associated cancer diagnosis, to give an overview of the age at onset in our cohort. During the follow-up period, 719 carriers were diagnosed with at least one Lynch-associated cancer and 171 were diagnosed with multiple Lynch-associated cancers. Overall, the median age of first diagnosis was 51 years (95% CI: 50–53), but this varied with mutational status, being 49 years in both <italic>MLH1</italic> and <italic>MSH2</italic> patients and 58 and 67 years, respectively, for <italic>MSH6</italic> and <italic>PMS2</italic> patients.</p>
<fig id="pgen.1007012.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007012.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Kaplan-Meier estimates of time to first Lynch-associated cancer diagnosis in the Swedish Registry data, both overall and stratified by mutational status.</title>
<p>The x axis displays age (years) and the y axis displays the probability of being free from diagnosis.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1007012.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pgen.1007012.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007012.t001</object-id>
<label>Table 1</label> <caption><title>Clinical characteristics of the analyzed LS cohort.</title></caption>
<alternatives>
<graphic id="pgen.1007012.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1007012.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="left">All</th>
<th align="left"><italic>MLH1</italic></th>
<th align="left"><italic>MSH2</italic></th>
<th align="left"><italic>MSH6</italic></th>
<th align="left"><italic>PMS2</italic><xref ref-type="table-fn" rid="t001fn001"><sup><italic>a</italic></sup></xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="2">Family-level characteristics</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">No. families</td>
<td align="left">239</td>
<td align="left">96</td>
<td align="left">90</td>
<td align="left">39</td>
<td align="left">14</td>
</tr>
<tr>
<td align="left">Mean No.</td>
<td align="left" rowspan="2">4.2</td>
<td align="left" rowspan="2">4.2</td>
<td align="left" rowspan="2">3.8</td>
<td align="left" rowspan="2">4.9</td>
<td align="left" rowspan="2">4.1</td>
</tr>
<tr>
<td align="left">carriers/fam</td>
</tr>
<tr>
<td align="left">Mean No. total diagnoses/fam</td>
<td align="left">3.0</td>
<td align="left">3.0</td>
<td align="left">3.0</td>
<td align="left">3.3</td>
<td align="left">2.4</td>
</tr>
<tr>
<td align="left">Mean No. generations/fam</td>
<td align="left">2.5</td>
<td align="left">2.6</td>
<td align="left">2.5</td>
<td align="left">2.6</td>
<td align="left">1.9</td>
</tr>
<tr>
<td align="left">Range No. generations/fam</td>
<td align="left">(1–5)</td>
<td align="left">(1–4)</td>
<td align="left">(1–5)</td>
<td align="left">(1–4)</td>
<td align="left">(1–3)</td>
</tr>
<tr>
<td align="left" colspan="3">Individual-level characteristics</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">No. carriers</td>
<td align="left">1003</td>
<td align="left">407</td>
<td align="left">345</td>
<td align="left">193</td>
<td align="left">58</td>
</tr>
<tr>
<td align="left" rowspan="2">Median age of first diagnosis (95% CI)</td>
<td align="left">51</td>
<td align="left">49</td>
<td align="left">49</td>
<td align="left">58</td>
<td align="left">67</td>
</tr>
<tr>
<td align="left">(50–53)</td>
<td align="left">(47–51)</td>
<td align="left">(48–51)</td>
<td align="left">(55–60)</td>
<td align="left">(58–75)</td>
</tr>
<tr>
<td align="left">Median follow-up</td>
<td align="left">72</td>
<td align="left">66</td>
<td align="left">Not reached</td>
<td align="left">69</td>
<td align="left">71</td>
</tr>
<tr>
<td align="left">% female</td>
<td align="left">52.2</td>
<td align="left">48.6</td>
<td align="left">51.0</td>
<td align="left">65.2</td>
<td align="left">41.4</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><sup><italic>a</italic></sup>Two families with germline mutations in both <italic>MLH1</italic> and <italic>PMS2</italic> are included in the <italic>PMS2</italic> category.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Based on this, in addition to adjusting for sex, we also included mutational status in NREM and COX-R analyses. <xref ref-type="table" rid="pgen.1007012.t002">Table 2</xref> gives the estimates, standard errors, and Wald-type <italic>p</italic>-values for the anticipation effects only, and <xref ref-type="table" rid="pgen.1007012.t003">Table 3</xref> provides all parameter estimates. As shown in <xref ref-type="table" rid="pgen.1007012.t002">Table 2</xref>, the estimates of <italic>γ</italic> (NREM) and <inline-formula id="pgen.1007012.e010"><alternatives><graphic id="pgen.1007012.e010g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e010" xlink:type="simple"/><mml:math display="inline" id="M10"><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:math></alternatives></inline-formula> (COX-R) are -2.1 (<italic>p</italic> = 0.0001) and 0.171 (<italic>p</italic> = 0.0013), respectively. Both suggest the presence of anticipation: a 2.1 year decrease in the age of diagnosis per generation and a hazard ratio of exp(0.171) = 1.19 between consecutive generations. Because mutational status appears to confound the age of diagnosis, we also investigated whether there were gene-specific effects of anticipation, yielding one estimated anticipation effect for each analyzed MMR-gene. These are given in the bottom rows of <xref ref-type="table" rid="pgen.1007012.t002">Table 2</xref>. In NREM, anticipation is estimated to be -1.8 (<italic>p</italic> = 0.044), -2.6 (<italic>p</italic> = 0.003), -1.1 (<italic>p</italic> = 0.366), and -7.3 (<italic>p</italic> = 0.014) years per generation respectively, for <italic>MLH1</italic>, <italic>MSH2</italic>, <italic>MSH6</italic>, and <italic>PMS2</italic>. In COX-R, the corresponding log-hazard ratios are 0.127 (<italic>p</italic> = 0.133), 0.284 (<italic>p</italic> = 0.001), -0.005 (<italic>p</italic> = 0.965), and 0.618 (<italic>p</italic> = 0.052), representing hazard ratios of 1.13, 1.33, 0.99, and 1.86, respectively. In both models, the confidence intervals (CIs) for the anticipation effects of <italic>MSH2</italic> and <italic>PMS2</italic> lie far from their null values (<xref ref-type="table" rid="pgen.1007012.t002">Table 2</xref>), whereas there is greater uncertainty with regard to any possible effect of anticipation in <italic>MLH1</italic> and <italic>MSH6</italic>.</p>
<table-wrap id="pgen.1007012.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007012.t002</object-id>
<label>Table 2</label> <caption><title>Results corresponding to the anticipation effects for the NREM and COX-R models, without and with the gene-generation interactions (Est = Estimate, CI = 95% Confidence Interval).</title></caption>
<alternatives>
<graphic id="pgen.1007012.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1007012.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center" colspan="3">NREM</th>
<th align="center" colspan="3">COX-R</th>
</tr>
<tr>
<th align="center">Model</th>
<th align="center">Parameter</th>
<th align="center">Est. (CI)</th>
<th align="center">Wald <italic>p</italic>-val</th>
<th align="center">Parameter</th>
<th align="center">Est. (CI)</th>
<th align="center">Wald <italic>p</italic>-val</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" rowspan="2">No. Interactions</td>
<td align="center" rowspan="2"><italic>γ</italic></td>
<td align="center">-2.10</td>
<td align="center" rowspan="2">0.0001</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e011"><alternatives><graphic id="pgen.1007012.e011g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e011" xlink:type="simple"/><mml:math display="inline" id="M11"><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:math></alternatives></inline-formula></td>
<td align="center">0.171</td>
<td align="center" rowspan="2">0.001</td>
</tr>
<tr>
<td align="left">(-3.16,-1.03)</td>
<td align="center">(0.066,0.275)</td>
</tr>
<tr>
<td align="center" rowspan="6">Gene-Generation Interactions</td>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MLH1</italic></sub></td>
<td align="center">-1.76</td>
<td align="center" rowspan="2">0.044</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e012"><alternatives><graphic id="pgen.1007012.e012g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e012" xlink:type="simple"/><mml:math display="inline" id="M12"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MLH</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.127</td>
<td align="center" rowspan="2">0.133</td>
</tr>
<tr>
<td align="center">(-3.46,-0.05)</td>
<td align="center">(-0.038,0.292)</td>
</tr>
<tr>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MSH2</italic></sub></td>
<td align="center">-2.55</td>
<td align="center" rowspan="2">0.003</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e013"><alternatives><graphic id="pgen.1007012.e013g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e013" xlink:type="simple"/><mml:math display="inline" id="M13"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.284</td>
<td align="center" rowspan="2">0.001</td>
</tr>
<tr>
<td align="center">(-4.22,-0.87)</td>
<td align="center">(0.123,0.446)</td>
</tr>
<tr>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MSH6</italic></sub></td>
<td align="center">-1.10</td>
<td align="center" rowspan="2">0.366</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e014"><alternatives><graphic id="pgen.1007012.e014g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e014" xlink:type="simple"/><mml:math display="inline" id="M14"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>6</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.005</td>
<td align="center" rowspan="2">0.965</td>
</tr>
<tr>
<td align="center">(-3.48,1.28)</td>
<td align="center">(-0.236,0.225)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>PMS2</italic></sub></td>
<td align="center">-7.33</td>
<td align="center" rowspan="2">0.014</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e015"><alternatives><graphic id="pgen.1007012.e015g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e015" xlink:type="simple"/><mml:math display="inline" id="M15"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">PMS</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.618</td>
<td align="center" rowspan="2">0.052</td>
</tr>
<tr>
<td align="center">(-13.2,-1.47)</td>
<td align="center">(-0.004,1.241)</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="pgen.1007012.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pgen.1007012.t003</object-id>
<label>Table 3</label> <caption><title>Complete results for the NREM and COX-R models, without and with the gene-generation interactions (Est = Estimate, CI = 95% Confidence Interval; SE = standard error).</title></caption>
<alternatives>
<graphic id="pgen.1007012.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1007012.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center" colspan="3">NREM</th>
<th align="center" colspan="3">COX-R</th>
</tr>
<tr>
<th align="center">Model</th>
<th align="center">Parameter</th>
<th align="center">Est. (CI)</th>
<th align="center">Wald <italic>p</italic>-val</th>
<th align="center">Parameter</th>
<th align="center">Est. (CI)</th>
<th align="center">Wald <italic>p</italic>-val</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" rowspan="4">No interactions</td>
<td align="center" rowspan="2"><italic>E(μ</italic><sub><italic>i</italic></sub><italic>)</italic></td>
<td align="center">53.2</td>
<td align="center" rowspan="2">&lt;0.0001</td>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
</tr>
<tr>
<td align="center">(50.6,55.8)</td>
</tr>
<tr>
<td align="center" rowspan="2"><italic>γ</italic></td>
<td align="center">-2.10</td>
<td align="center" rowspan="2">0.0001</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e016"><alternatives><graphic id="pgen.1007012.e016g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e016" xlink:type="simple"/><mml:math display="inline" id="M16"><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:math></alternatives></inline-formula></td>
<td align="center">0.171</td>
<td align="center" rowspan="2">0.001</td>
</tr>
<tr>
<td align="center">(-3.16,-1.03)</td>
<td align="center">(0.066,0.275)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>sex</italic></sub></td>
<td align="center" rowspan="2">0.82</td>
<td align="center" rowspan="3">0.352</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e017"><alternatives><graphic id="pgen.1007012.e017g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e017" xlink:type="simple"/><mml:math display="inline" id="M17"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">sex</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.121</td>
<td align="center" rowspan="3">0.138</td>
</tr>
<tr>
<td align="center" rowspan="2">(-0.280,0.039)</td>
</tr>
<tr>
<td align="center">(-0.91,2.55)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>MSH2</italic></sub></td>
<td align="center">-0.08</td>
<td align="center" rowspan="3">0.945</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e018"><alternatives><graphic id="pgen.1007012.e018g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e018" xlink:type="simple"/><mml:math display="inline" id="M18"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center" rowspan="2">0.003</td>
<td align="center" rowspan="3">0.980</td>
</tr>
<tr>
<td align="center" rowspan="2">(-2.23,2.08)</td>
</tr>
<tr>
<td align="center">(-0.197,0.202)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>β</italic><sub><italic>MSH6</italic></sub></td>
<td align="center">7.83</td>
<td align="center" rowspan="2">&lt;0.0001</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e019"><alternatives><graphic id="pgen.1007012.e019g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e019" xlink:type="simple"/><mml:math display="inline" id="M19"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>6</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.655</td>
<td align="center" rowspan="2">&lt;0.0001</td>
</tr>
<tr>
<td align="center">(5.14,10.5)</td>
<td align="center">(-0.910,-0.400)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>PMS2</italic></sub></td>
<td align="center" rowspan="2">11.35</td>
<td align="center" rowspan="3">&lt;0.0001</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e020"><alternatives><graphic id="pgen.1007012.e020g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e020" xlink:type="simple"/><mml:math display="inline" id="M20"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">PMS</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.939</td>
<td align="center" rowspan="3">&lt;0.0001</td>
</tr>
<tr>
<td align="center" rowspan="2">(-1.374,-0.504)</td>
</tr>
<tr>
<td align="center">(6.89,15.8)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>Var(μ</italic><sub><italic>i</italic></sub><italic>)</italic></td>
<td align="center">9.53</td>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e021"><alternatives><graphic id="pgen.1007012.e021g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e021" xlink:type="simple"/><mml:math display="inline" id="M21"><mml:mi mathvariant="italic">Var</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula></td>
<td align="center" rowspan="2">0.101</td>
<td align="center" rowspan="2"/>
</tr>
<tr>
<td align="center">(SE = 4.66)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>Var(ε</italic><sub><italic>ij</italic></sub><italic>)</italic></td>
<td align="center">151.5</td>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
</tr>
<tr>
<td align="center">(SE = 8.96)</td>
</tr>
<tr>
<td align="center" rowspan="5">Gene-Generation Interactions</td>
<td align="center"><italic>E(μ</italic><sub><italic>i</italic></sub><italic>)</italic></td>
<td align="center">52.2 (1.8)</td>
<td align="center">&lt;0.0001</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MLH1</italic></sub></td>
<td align="center">-1.76</td>
<td align="center" rowspan="2">0.044</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e022"><alternatives><graphic id="pgen.1007012.e022g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e022" xlink:type="simple"/><mml:math display="inline" id="M22"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MLH</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.127</td>
<td align="center" rowspan="2">0.133</td>
</tr>
<tr>
<td align="center">(-3.46,-0.05)</td>
<td align="center">(-0.038,0.292)</td>
</tr>
<tr>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MSH2</italic></sub></td>
<td align="center">-2.55</td>
<td align="center" rowspan="2">0.003</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e023"><alternatives><graphic id="pgen.1007012.e023g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e023" xlink:type="simple"/><mml:math display="inline" id="M23"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.284</td>
<td align="center" rowspan="2">0.001</td>
</tr>
<tr>
<td align="center">(-4.22,-0.87)</td>
<td align="center">(0.123,0.446)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>MSH6</italic></sub></td>
<td align="center">-1.10</td>
<td align="center" rowspan="2">0.366</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e024"><alternatives><graphic id="pgen.1007012.e024g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e024" xlink:type="simple"/><mml:math display="inline" id="M24"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>6</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.005</td>
<td align="center" rowspan="2">0.965</td>
</tr>
<tr>
<td align="center">(-3.48,1.28)</td>
<td align="center">(-0.236,0.225)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>γ</italic><sub><italic>PMS2</italic></sub></td>
<td align="center">-7.33</td>
<td align="center" rowspan="2">0.014</td>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e025"><alternatives><graphic id="pgen.1007012.e025g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e025" xlink:type="simple"/><mml:math display="inline" id="M25"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">PMS</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">0.618</td>
<td align="center" rowspan="2">0.052</td>
</tr>
<tr>
<td align="center">(-13.2,-1.47)</td>
<td align="center">(-0.004,1.241)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>sex</italic></sub></td>
<td align="center" rowspan="2">0.87</td>
<td align="center" rowspan="3">0.328</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e026"><alternatives><graphic id="pgen.1007012.e026g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e026" xlink:type="simple"/><mml:math display="inline" id="M26"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">sex</mml:mi></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.125</td>
<td align="center" rowspan="3">0.126</td>
</tr>
<tr>
<td align="center" rowspan="2">(-0.285,0.035)</td>
</tr>
<tr>
<td align="center">(-0.85,2.59)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>MSH2</italic></sub></td>
<td align="center" rowspan="2">1.39</td>
<td align="center" rowspan="3">0.495</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e027"><alternatives><graphic id="pgen.1007012.e027g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e027" xlink:type="simple"/><mml:math display="inline" id="M27"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.270</td>
<td align="center" rowspan="3">0.231</td>
</tr>
<tr>
<td align="center" rowspan="2">(-0.712,0.172)</td>
</tr>
<tr>
<td align="center">(-3.49,6.28)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>MSH6</italic></sub></td>
<td align="center" rowspan="2">6.53</td>
<td align="center" rowspan="3">0.029</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e028"><alternatives><graphic id="pgen.1007012.e028g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e028" xlink:type="simple"/><mml:math display="inline" id="M28"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">MSH</mml:mi><mml:mn>6</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-0.415</td>
<td align="center" rowspan="3">0.146</td>
</tr>
<tr>
<td align="center" rowspan="2">(-0.974,0.145)</td>
</tr>
<tr>
<td align="center">(0.39,12.7)</td>
</tr>
<tr>
<td align="center" rowspan="3"/>
<td align="center" rowspan="3"><italic>β</italic><sub><italic>PMS2</italic></sub></td>
<td align="center" rowspan="2">19.4</td>
<td align="center" rowspan="3">&lt;0.0001</td>
<td align="center" rowspan="3"><inline-formula id="pgen.1007012.e029"><alternatives><graphic id="pgen.1007012.e029g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e029" xlink:type="simple"/><mml:math display="inline" id="M29"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi mathvariant="italic">PMS</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:math></alternatives></inline-formula></td>
<td align="center">-1.61</td>
<td align="center" rowspan="3">0.002</td>
</tr>
<tr>
<td align="center" rowspan="2">(-2.62,-0.608)</td>
</tr>
<tr>
<td align="center">(9.41,29.3)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>Var(μ</italic><sub><italic>i</italic></sub><italic>)</italic></td>
<td align="center">9.81</td>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><inline-formula id="pgen.1007012.e030"><alternatives><graphic id="pgen.1007012.e030g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pgen.1007012.e030" xlink:type="simple"/><mml:math display="inline" id="M30"><mml:mi mathvariant="italic">Var</mml:mi><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>˜</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></alternatives></inline-formula></td>
<td align="center" rowspan="2">0.109</td>
<td align="center" rowspan="2"/>
</tr>
<tr>
<td align="center">(SE = 4.76)</td>
</tr>
<tr>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"><italic>Var(ε</italic><sub><italic>ij</italic></sub><italic>)</italic></td>
<td align="center">150.4</td>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
</tr>
<tr>
<td align="center">(SE = 8.94)</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec004" sec-type="conclusions">
<title>Discussion</title>
<p>We investigated signs of anticipation in LS through the analysis of a large, Swedish population-based cohort and regression analyses suggest that anticipation exists in these families. The NREM analysis suggests that the age of diagnosis in families is decreasing by about 2 years per generation, and the COX-R analysis suggests a multiplicative increase in the rate of diagnosis of about 1.19 between generations. These regression analyses carry at least two important advantages over hypothesis testing approaches that compare the age of diagnosis between all parent-child pairs. First, they make use of the partial follow-up time from all at-risk carriers who have not yet been diagnosed; these individuals would otherwise be excluded from analysis. Second, the model-based structure allows for straightforward incorporation of genetic effects or other possible confounders. The underlying causal mutation evidently plays a role in the extent of anticipation, as our estimates varied between MMR genes. Among the MMR genes, the ordering of estimated anticipation effects was <italic>PMS2</italic>, <italic>MSH2</italic>, <italic>MLH1</italic>, and <italic>MSH6</italic>, with the largest effect in <italic>PMS2</italic> (7.3 years/generation [NREM] or a hazard ratio of exp(0.618) = 1.86 [COX-R]). Although the small number of <italic>PMS2</italic> families yielded correspondingly large uncertainty, these effects were still highly significant therefore this uncertainty does not invalidate the findings. For <italic>MSH2</italic>, the estimated effect of anticipation was 2.6 years/generation or a hazard ratio of exp(0.284) = 1.33.</p>
<p>The results are comparable to those reported in several earlier studies (for a review, see [<xref ref-type="bibr" rid="pgen.1007012.ref041">41</xref>]). In an analysis of Lynch families from the Danish HNPCC Registry [<xref ref-type="bibr" rid="pgen.1007012.ref045">45</xref>], an anticipation effect of about three years/generation was reported but no differences between mutational status was found. A version of the same data was considered again in Boonstra, et al. [<xref ref-type="bibr" rid="pgen.1007012.ref043">43</xref>], who fit variants of both regression models considered here, reporting effects of 3.3 years/generation and hazard ratios of exp(0.22) = 1.25. Neither model in that study adjusted for mutational status. Also, the Cox model did not include family-level random effects, as we do here; our approach is arguably a more accurate, although still simplified, reproduction of the true underlying hazard process. A later report analyzed the same Danish HNPCC Registry data with Bayesian modeling techniques [<xref ref-type="bibr" rid="pgen.1007012.ref059">59</xref>], allowing anticipation to be random between families. They estimated population-level gene-specific effects of anticipation, as performed here, for <italic>MLH1</italic>, <italic>MSH2</italic>, and <italic>MSH6</italic>. They found respective anticipation effects of 2.8, 2.5, and 1.0 years, consistent with our findings. Several other studies based on anecdotal observation or analyses of affected parent-child pairs have found effects of anticipation varying between 5.5 and 10 years [<xref ref-type="bibr" rid="pgen.1007012.ref044">44</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref047">47</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref049">49</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref050">50</xref>]. A notable exception from previous studies is Tsai, et al. [<xref ref-type="bibr" rid="pgen.1007012.ref046">46</xref>] who found no evidence for anticipation in 475 parent-child pairs from the Johns Hopkins Hereditary Colorectal Cancer Registry; in part this may be explained by differences in eligibility as only 14 of the 475 parent-child pairs analyzed had verified disease-predispoing germline MMR gene mutations.</p>
<p>The underlying mechanism for anticipation in heritable cancer is still unknown. However, it has been proposed that anticipation is caused by a progressive accumulation of germline mutations, due to the reduced DNA mismatch repair ability in mutation carriers [<xref ref-type="bibr" rid="pgen.1007012.ref051">51</xref>]. Accordingly, haploid/monoallelic mutations in the MMR system affect the mutation load in the carrier prior to loss of the second allele, and accumulated alterations in the germ cells is transferred to the offspring [<xref ref-type="bibr" rid="pgen.1007012.ref041">41</xref>]. Interestingly, there is an overrepresentation of mononucleotide repeats within and around the human MMR genes compared to other genomic regions, with an overrepresentation in the <italic>PMS2</italic> gene [<xref ref-type="bibr" rid="pgen.1007012.ref060">60</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref061">61</xref>]. It has been suggested that MMR proteins maintain the length of such microsatellites present within their own nucleotide sequences by an evolutionary mechanism operating by gene-protein interactions [<xref ref-type="bibr" rid="pgen.1007012.ref060">60</xref>]. With the above arguments a deficient MMR system would propagate errors through generations and this would be most significant for mutations in the <italic>PMS2</italic> gene, which is in accordance with our results. In addition, it has been shown that <italic>PMS2</italic>-deficient mice eggs forms embryos with an increased mononucleotide mutation rate, indicating that MMR mutations might affect germline mutation rate in a heterozygous state [<xref ref-type="bibr" rid="pgen.1007012.ref062">62</xref>]. This also points to our results that <italic>PMS2</italic> mutations carriers would display the most anticipation if the mutation load is inherited by the next generation.</p>
<p>Noteworthy, <italic>PMS2</italic> and <italic>MSH2</italic> are not part of the same protein complex involved in recognition, excision and resynthesis of mismatched nucleotides [<xref ref-type="bibr" rid="pgen.1007012.ref063">63</xref>], nor does the <italic>MSH2</italic> gene contain the same magnitude of mononucleotide repeats as <italic>PMS2</italic> [<xref ref-type="bibr" rid="pgen.1007012.ref060">60</xref>]. This together suggests a different underlying mechanism generating anticipation in <italic>MSH2</italic> mutation carriers. For example, it is shown that MMR deficiency affect telomere shortening in human fibroblasts, and that this might influence heterozygous carriers of a <italic>MSH2</italic> mutation in particular [<xref ref-type="bibr" rid="pgen.1007012.ref064">64</xref>]. Moreover, in a recent study telomere shortening correlated significantly with age at onset in the <italic>MSH2</italic> carriers, whereas the <italic>MLH1</italic> carriers displayed longer telomeres and delayed age at onset [<xref ref-type="bibr" rid="pgen.1007012.ref065">65</xref>]. Nevertheless, MMR mutation carriers with LS-associated cancer may have specific telomere-length dynamics but telomere shortening does not alone explain anticipation, as reported by Segui et al [<xref ref-type="bibr" rid="pgen.1007012.ref066">66</xref>], indicating that gene-specific dynamics and different mechanisms are involved.</p>
<p>Despite a general concurrence with earlier studies, several caveats accompany our findings. Evidently, our study and previously published evidence that performed survival analysis for genetic anticipation in LS suggests that if genetic anticipation does exist, the effect is modest [<xref ref-type="bibr" rid="pgen.1007012.ref042">42</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref043">43</xref>,<xref ref-type="bibr" rid="pgen.1007012.ref045">45</xref>]. This makes anticipation a difficult problem statistically and challenges some of the clinical utility of our findings. At the population level, anticipation may well also be due to reasons other than genetic. For example, cohort effects arising from changes in treatment, diagnostic or environmental factors can also result in a decline in age at diagnosis. These effects should be visible both within family trees and in the entire population (which is a mix of mutation carriers from different generations). This is in contrast to genetic anticipation, which would only be seen within each unique family tree.</p>
<p>Voskuil, et al. found that the hazard ratio corresponding to generation decreased considerably in magnitude after adjusting for birth cohort [<xref ref-type="bibr" rid="pgen.1007012.ref042">42</xref>], although their final estimated hazard ratios for the effect of generation were still very close to our estimate of 1.2. Statistically, birth cohort and generation are typically highly correlated, which can cause the resulting parameter estimates to be unstable. Boonstra, et al. [<xref ref-type="bibr" rid="pgen.1007012.ref059">59</xref>] attempted to disentangle these effects by independently estimating secular trends in age of colorectal cancer diagnosis from a cancer registry of all colorectal cancers, and adjusting the Danish HNPCC Registry data for this estimated trend before analysis. Still, the results indicated as reported earlier in this section, population-level gene-specific effects of anticipation of 2.8, 2.5, and 1.0 years, respectively, for <italic>MLH1</italic>, <italic>MSH2</italic>, and <italic>MSH6</italic>. Our estimated effects of anticipation decrease by about 0.7 years when we directly apply the secular trends estimated in Boonstra, et al. [<xref ref-type="bibr" rid="pgen.1007012.ref054">54</xref>].</p>
<p>Furthermore, it has been argued that anticipation may be falsely detected due to fecundity bias [<xref ref-type="bibr" rid="pgen.1007012.ref048">48</xref>]. Through repeated simulations of parent-child pairs in which no anticipation exists (in truth) but the fertility rate was positively correlated with age of diagnosis, Stupart, et al. demonstrated in a particular scenario that an apparent anticipation effect of about 1.8 years can manifest. Noteworthy, the greatest reduction in fertility was predominantly among those diagnosed before age 29, affecting the fertility of the cohort as a whole. In our cohort, the Kaplan-Meier estimated proportion of patients free of diagnosis at age 29 was 96.5%, which suggests that fecundity bias due to these patients is likely to be small.</p>
<p>Taken together, our findings are in line with those of previous studies. That being said, the study of genetic anticipation is both complex and statistically challenging. The ideal setting in the continuing assessment of fine variations in LS phenotype, such as anticipation, would be prospective, population-based datasets, together with state-of-the-art statistical methods. Still, a number of promising findings have been reported previously, yet often the statistical methods or small sample sizes have been limiting. We believe that the analyses performed in our study properly consider familial, genetic, and clinical parameters and therefore give a representative measurement of anticipation in Lynch Syndrome.</p>
</sec>
</body>
<back>
<ack>
<p>We thank the regional Oncogenetic Clinics in Lindköping, Lund, Stockholm, Umeå and Uppsala for contributing with patient data.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pgen.1007012.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Blanco</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Aktan-Collan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Gopie</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Alonso</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aretz</surname> <given-names>S</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts</article-title>. <source>Gut</source> <volume>62</volume>: <fpage>812</fpage>–<lpage>823</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/gutjnl-2012-304356" xlink:type="simple">10.1136/gutjnl-2012-304356</ext-link></comment> <object-id pub-id-type="pmid">23408351</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Riley</surname> <given-names>B</given-names></name> (<year>2005</year>) <article-title>The tumor spectrum in the Lynch syndrome</article-title>. <source>Fam Cancer</source> <volume>4</volume>: <fpage>245</fpage>–<lpage>248</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-004-7994-z" xlink:type="simple">10.1007/s10689-004-7994-z</ext-link></comment> <object-id pub-id-type="pmid">16136385</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Watson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mecklin</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>HT</given-names></name> (<year>1999</year>) <article-title>New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC</article-title>. <source>Gastroenterology</source> <volume>116</volume>: <fpage>1453</fpage>–<lpage>1456</lpage>. <object-id pub-id-type="pmid">10348829</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Umar</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Boland</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Terdiman</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Syngal</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>de la Chapelle</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruschoff</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability</article-title>. <source>J Natl Cancer Inst</source> <volume>96</volume>: <fpage>261</fpage>–<lpage>268</lpage>. <object-id pub-id-type="pmid">14970275</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jass</surname> <given-names>JR</given-names></name> (<year>2006</year>) <article-title>Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term</article-title>. <source>World J Gastroenterol</source> <volume>12</volume>: <fpage>4943</fpage>–<lpage>4950</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3748/wjg.v12.i31.4943" xlink:type="simple">10.3748/wjg.v12.i31.4943</ext-link></comment> <object-id pub-id-type="pmid">16937488</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boland</surname> <given-names>CR</given-names></name> (<year>2005</year>) <article-title>Evolution of the nomenclature for the hereditary colorectal cancer syndromes</article-title>. <source>Fam Cancer</source> <volume>4</volume>: <fpage>211</fpage>–<lpage>218</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-004-4489-x" xlink:type="simple">10.1007/s10689-004-4489-x</ext-link></comment> <object-id pub-id-type="pmid">16136380</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ligtenberg</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Kuiper</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Geurts van Kessel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hoogerbrugge</surname> <given-names>N</given-names></name> (<year>2013</year>) <article-title>EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients</article-title>. <source>Fam Cancer</source> <volume>12</volume>: <fpage>169</fpage>–<lpage>174</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-012-9591-x" xlink:type="simple">10.1007/s10689-012-9591-x</ext-link></comment> <object-id pub-id-type="pmid">23264089</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Modrich</surname> <given-names>P</given-names></name> (<year>2006</year>) <article-title>Mechanisms in eukaryotic mismatch repair</article-title>. <source>J Biol Chem</source> <volume>281</volume>: <fpage>30305</fpage>–<lpage>30309</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.R600022200" xlink:type="simple">10.1074/jbc.R600022200</ext-link></comment> <object-id pub-id-type="pmid">16905530</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kloor</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Staffa</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ahadova</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>von Knebel Doeberitz</surname> <given-names>M</given-names></name> (<year>2014</year>) <article-title>Clinical significance of microsatellite instability in colorectal cancer</article-title>. <source>Langenbecks Arch Surg</source> <volume>399</volume>: <fpage>23</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00423-013-1112-3" xlink:type="simple">10.1007/s00423-013-1112-3</ext-link></comment> <object-id pub-id-type="pmid">24048684</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>You</surname> <given-names>YN</given-names></name> (<year>2015</year>) <article-title>Anticipating phenotypic differences from genetic mutations</article-title>. <source>Dis Colon Rectum</source> <volume>58</volume>: <fpage>143</fpage>–<lpage>144</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/DCR.0000000000000271" xlink:type="simple">10.1097/DCR.0000000000000271</ext-link></comment> <object-id pub-id-type="pmid">25489706</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Plaschke</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Engel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kruger</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Holinski-Feder</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pagenstecher</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mangold</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium</article-title>. <source>J Clin Oncol</source> <volume>22</volume>: <fpage>4486</fpage>–<lpage>4494</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2004.02.033" xlink:type="simple">10.1200/JCO.2004.02.033</ext-link></comment> <object-id pub-id-type="pmid">15483016</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kastrinos</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Stoffel</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Balmana</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Steyerberg</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Mercado</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Syngal</surname> <given-names>S</given-names></name> (<year>2008</year>) <article-title>Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>17</volume>: <fpage>2044</fpage>–<lpage>2051</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-08-0301" xlink:type="simple">10.1158/1055-9965.EPI-08-0301</ext-link></comment> <object-id pub-id-type="pmid">18708397</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goecke</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Schulmann</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Engel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Holinski-Feder</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pagenstecher</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Schackert</surname> <given-names>HK</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium</article-title>. <source>J Clin Oncol</source> <volume>24</volume>: <fpage>4285</fpage>–<lpage>4292</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2005.03.7333" xlink:type="simple">10.1200/JCO.2005.03.7333</ext-link></comment> <object-id pub-id-type="pmid">16908935</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Stormorken</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Menko</surname> <given-names>FH</given-names></name>, <name name-style="western"><surname>Nagengast</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Kleibeuker</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Griffioen</surname> <given-names>G</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families</article-title>. <source>J Clin Oncol</source> <volume>19</volume>: <fpage>4074</fpage>–<lpage>4080</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2001.19.20.4074" xlink:type="simple">10.1200/JCO.2001.19.20.4074</ext-link></comment> <object-id pub-id-type="pmid">11600610</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hampel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Stephens</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Pukkala</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Sankila</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Aaltonen</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Mecklin</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset</article-title>. <source>Gastroenterology</source> <volume>129</volume>: <fpage>415</fpage>–<lpage>421</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gastro.2005.05.011" xlink:type="simple">10.1016/j.gastro.2005.05.011</ext-link></comment> <object-id pub-id-type="pmid">16083698</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wagner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hendriks</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Meijers-Heijboer</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>de Leeuw</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Morreau</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hofstra</surname> <given-names>R</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree</article-title>. <source>J Med Genet</source> <volume>38</volume>: <fpage>318</fpage>–<lpage>322</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jmg.38.5.318" xlink:type="simple">10.1136/jmg.38.5.318</ext-link></comment> <object-id pub-id-type="pmid">11333868</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peterlongo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Nafa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lerman</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Glogowski</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Shia</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>TZ</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>MSH6 germline mutations are rare in colorectal cancer families</article-title>. <source>Int J Cancer</source> <volume>107</volume>: <fpage>571</fpage>–<lpage>579</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.11415" xlink:type="simple">10.1002/ijc.11415</ext-link></comment> <object-id pub-id-type="pmid">14520694</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kolodner</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Tytell</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Schmeits</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Kane</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Gupta</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Weger</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Germ-line msh6 mutations in colorectal cancer families</article-title>. <source>Cancer Res</source> <volume>59</volume>: <fpage>5068</fpage>–<lpage>5074</lpage>. <object-id pub-id-type="pmid">10537275</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baglietto</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lindor</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Dowty</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gomez Garcia</surname> <given-names>EB</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Risks of Lynch syndrome cancers for MSH6 mutation carriers</article-title>. <source>J Natl Cancer Inst</source> <volume>102</volume>: <fpage>193</fpage>–<lpage>201</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jnci/djp473" xlink:type="simple">10.1093/jnci/djp473</ext-link></comment> <object-id pub-id-type="pmid">20028993</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wijnen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>de Leeuw</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Vasen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>van der Klift</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Moller</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Stormorken</surname> <given-names>A</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Familial endometrial cancer in female carriers of MSH6 germline mutations</article-title>. <source>Nat Genet</source> <volume>23</volume>: <fpage>142</fpage>–<lpage>144</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/13773" xlink:type="simple">10.1038/13773</ext-link></comment> <object-id pub-id-type="pmid">10508506</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gala</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chung</surname> <given-names>DC</given-names></name> (<year>2011</year>) <article-title>Hereditary colon cancer syndromes</article-title>. <source>Semin Oncol</source> <volume>38</volume>: <fpage>490</fpage>–<lpage>499</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.seminoncol.2011.05.003" xlink:type="simple">10.1053/j.seminoncol.2011.05.003</ext-link></comment> <object-id pub-id-type="pmid">21810508</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jasperson</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Tuohy</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Neklason</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Burt</surname> <given-names>RW</given-names></name> (<year>2010</year>) <article-title>Hereditary and familial colon cancer</article-title>. <source>Gastroenterology</source> <volume>138</volume>: <fpage>2044</fpage>–<lpage>2058</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2010.01.054" xlink:type="simple">10.1053/j.gastro.2010.01.054</ext-link></comment> <object-id pub-id-type="pmid">20420945</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lynch</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Smyrk</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Watson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lanspa</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>PM</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review</article-title>. <source>Gastroenterology</source> <volume>104</volume>: <fpage>1535</fpage>–<lpage>1549</lpage>. <object-id pub-id-type="pmid">8482467</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scott</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>McPhillips</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Meldrum</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Fitzgerald</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Spigelman</surname> <given-names>AD</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds</article-title>. <source>Am J Hum Genet</source> <volume>68</volume>: <fpage>118</fpage>–<lpage>127</lpage>. <object-id pub-id-type="pmid">11112663</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rebbeck</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Martinez</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Sellers</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Shields</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Wild</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Potter</surname> <given-names>JD</given-names></name> (<year>2004</year>) <article-title>Genetic variation and cancer: improving the environment for publication of association studies</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>13</volume>: <fpage>1985</fpage>–<lpage>1986</lpage>. <object-id pub-id-type="pmid">15598750</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reeves</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Rich</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Meldrum</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Colyvas</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kurzawski</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Suchy</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>IGF1 is a modifier of disease risk in hereditary non-polyposis colorectal cancer</article-title>. <source>Int J Cancer</source> <volume>123</volume>: <fpage>1339</fpage>–<lpage>1343</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.23668" xlink:type="simple">10.1002/ijc.23668</ext-link></comment> <object-id pub-id-type="pmid">18623088</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kruger</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Silber</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Engel</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gorgens</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Mangold</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pagenstecher</surname> <given-names>C</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study</article-title>. <source>Lancet Oncol</source> <volume>6</volume>: <fpage>566</fpage>–<lpage>572</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(05)70253-9" xlink:type="simple">10.1016/S1470-2045(05)70253-9</ext-link></comment> <object-id pub-id-type="pmid">16054567</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Johnstone</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Talseth-Palmer</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Evans</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Spigelman</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Groombridge</surname> <given-names>C</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age</article-title>. <source>Int J Cancer</source> <volume>125</volume>: <fpage>78</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.24304" xlink:type="simple">10.1002/ijc.24304</ext-link></comment> <object-id pub-id-type="pmid">19291797</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pande</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Amos</surname> <given-names>CI</given-names></name>, <name name-style="western"><surname>Talseth-Palmer</surname> <given-names>BA</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients</article-title>. <source>Carcinogenesis</source> <volume>34</volume>: <fpage>299</fpage>–<lpage>306</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/carcin/bgs344" xlink:type="simple">10.1093/carcin/bgs344</ext-link></comment> <object-id pub-id-type="pmid">23125224</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pande</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Amos</surname> <given-names>CI</given-names></name>, <name name-style="western"><surname>Osterwisch</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Broaddus</surname> <given-names>R</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>17</volume>: <fpage>2393</fpage>–<lpage>2401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-08-0326" xlink:type="simple">10.1158/1055-9965.EPI-08-0326</ext-link></comment> <object-id pub-id-type="pmid">18768509</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bellido</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Guino</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Jagmohan-Changur</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Segui</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Pineda</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Navarro</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome</article-title>. <source>Eur J Hum Genet</source> <volume>21</volume>: <fpage>511</fpage>–<lpage>516</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ejhg.2012.204" xlink:type="simple">10.1038/ejhg.2012.204</ext-link></comment> <object-id pub-id-type="pmid">22948024</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Plassart</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Fontaine</surname> <given-names>B</given-names></name> (<year>1994</year>) <article-title>Genes with triplet repeats: a new class of mutations causing neurological diseases</article-title>. <source>Biomed Pharmacother</source> <volume>48</volume>: <fpage>191</fpage>–<lpage>197</lpage>. <object-id pub-id-type="pmid">7999979</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldstein</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>WH</given-names> <suffix>Jr.</suffix></name>, <name name-style="western"><surname>Fraser</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Tucker</surname> <given-names>MA</given-names></name> (<year>1996</year>) <article-title>Apparent anticipation in familial melanoma</article-title>. <source>Melanoma Res</source> <volume>6</volume>: <fpage>441</fpage>–<lpage>446</lpage>. <object-id pub-id-type="pmid">9013482</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trkova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hladikova</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kasal</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Goetz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sedlacek</surname> <given-names>Z</given-names></name> (<year>2002</year>) <article-title>Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?</article-title> <source>J Hum Genet</source> <volume>47</volume>: <fpage>381</fpage>–<lpage>386</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s100380200055" xlink:type="simple">10.1007/s100380200055</ext-link></comment> <object-id pub-id-type="pmid">12181637</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez-Borges</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Petty</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Hurt</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Stribling</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Press</surname> <given-names>JZ</given-names></name>, <name name-style="western"><surname>Castellino</surname> <given-names>SM</given-names></name> (<year>2009</year>) <article-title>Familial small cell carcinoma of the ovary</article-title>. <source>Pediatr Blood Cancer</source> <volume>53</volume>: <fpage>1334</fpage>–<lpage>1336</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/pbc.22184" xlink:type="simple">10.1002/pbc.22184</ext-link></comment> <object-id pub-id-type="pmid">19621450</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schneider</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Slater</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>Sina</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Habbe</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Fendrich</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Matthai</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>German national case collection for familial pancreatic cancer (FaPaCa): ten years experience</article-title>. <source>Fam Cancer</source> <volume>10</volume>: <fpage>323</fpage>–<lpage>330</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-010-9414-x" xlink:type="simple">10.1007/s10689-010-9414-x</ext-link></comment> <object-id pub-id-type="pmid">21207249</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ning</surname> <given-names>XH</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>XY</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families</article-title>. <source>Cancer Res</source> <volume>74</volume>: <fpage>3802</fpage>–<lpage>3809</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/0008-5472.CAN-14-0024" xlink:type="simple">10.1158/0008-5472.CAN-14-0024</ext-link></comment> <object-id pub-id-type="pmid">24986515</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Yong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ooi</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Ngeow</surname> <given-names>J</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC)</article-title>. <source>Fam Cancer</source> <volume>13</volume>: <fpage>281</fpage>–<lpage>289</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-014-9703-x" xlink:type="simple">10.1007/s10689-014-9703-x</ext-link></comment> <object-id pub-id-type="pmid">24526232</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guindalini</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fackenthal</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Olopade</surname> <given-names>OI</given-names></name>, <name name-style="western"><surname>Huo</surname> <given-names>D</given-names></name> (<year>2016</year>) <article-title>Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect</article-title>. <source>Cancer</source> <volume>122</volume>: <fpage>1913</fpage>–<lpage>1920</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.29972" xlink:type="simple">10.1002/cncr.29972</ext-link></comment> <object-id pub-id-type="pmid">26992017</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Warthin</surname> <given-names>AS</given-names></name> (<year>1925</year>) <article-title>The Further Study of a Cancer Family</article-title>. <source>The Journal of Cancer Research</source> <volume>9</volume>: <fpage>279</fpage>–<lpage>286</lpage>.</mixed-citation></ref>
<ref id="pgen.1007012.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bozzao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lastella</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Stella</surname> <given-names>A</given-names></name> (<year>2011</year>) <article-title>Anticipation in lynch syndrome: where we are where we go</article-title>. <source>Curr Genomics</source> <volume>12</volume>: <fpage>451</fpage>–<lpage>465</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2174/138920211797904070" xlink:type="simple">10.2174/138920211797904070</ext-link></comment> <object-id pub-id-type="pmid">22547953</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voskuil</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Vasen</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Kampman</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>van't Veer</surname> <given-names>P</given-names></name> (<year>1997</year>) <article-title>Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National Collaborative Group on HNPCC</article-title>. <source>Int J Cancer</source> <volume>72</volume>: <fpage>205</fpage>–<lpage>209</lpage>. <object-id pub-id-type="pmid">9219821</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boonstra</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Gruber</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Raymond</surname> <given-names>VM</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Timshel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nilbert</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome</article-title>. <source>Genet Epidemiol</source> <volume>34</volume>: <fpage>756</fpage>–<lpage>768</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/gepi.20534" xlink:type="simple">10.1002/gepi.20534</ext-link></comment> <object-id pub-id-type="pmid">20878717</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nilbert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Timshel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bernstein</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>K</given-names></name> (<year>2009</year>) <article-title>Role for genetic anticipation in Lynch syndrome</article-title>. <source>J Clin Oncol</source> <volume>27</volume>: <fpage>360</fpage>–<lpage>364</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2008.16.1281" xlink:type="simple">10.1200/JCO.2008.16.1281</ext-link></comment> <object-id pub-id-type="pmid">19075283</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bernstein</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Nilbert</surname> <given-names>M</given-names></name> (<year>2009</year>) <article-title>A parametric model for analyzing anticipation in genetically predisposed families</article-title>. <source>Stat Appl Genet Mol Biol</source> <volume>8</volume>: Article26.</mixed-citation></ref>
<ref id="pgen.1007012.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsai</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Booker</surname> <given-names>SV</given-names></name>, <name name-style="western"><surname>Bacon</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Hamilton</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Giardiello</surname> <given-names>FM</given-names></name> (<year>1997</year>) <article-title>Evidence against genetic anticipation in familial colorectal cancer</article-title>. <source>Genet Epidemiol</source> <volume>14</volume>: <fpage>435</fpage>–<lpage>446</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/(SICI)1098-2272(1997)14:4&lt;435::AID-GEPI8&gt;3.0.CO;2-1" xlink:type="simple">10.1002/(SICI)1098-2272(1997)14:4&lt;435::AID-GEPI8&gt;3.0.CO;2-1</ext-link></comment> <object-id pub-id-type="pmid">9271715</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Westphalen</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Russell</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Buser</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Berthod</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Hutter</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Plasilova</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer</article-title>. <source>Hum Genet</source> <volume>116</volume>: <fpage>461</fpage>–<lpage>465</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00439-005-1272-5" xlink:type="simple">10.1007/s00439-005-1272-5</ext-link></comment> <object-id pub-id-type="pmid">15772852</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stupart</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Algar</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Vorster</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ramesar</surname> <given-names>R</given-names></name> (<year>2014</year>) <article-title>No evidence of genetic anticipation in a large family with Lynch syndrome</article-title>. <source>Fam Cancer</source> <volume>13</volume>: <fpage>29</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10689-013-9669-0" xlink:type="simple">10.1007/s10689-013-9669-0</ext-link></comment> <object-id pub-id-type="pmid">23771324</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname> <given-names>HF</given-names></name>, <name name-style="western"><surname>Taal</surname> <given-names>BG</given-names></name>, <name name-style="western"><surname>Griffioen</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nagengast</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Cats</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Menko</surname> <given-names>FH</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols</article-title>. <source>Gut</source> <volume>35</volume>: <fpage>1262</fpage>–<lpage>1266</lpage>. <object-id pub-id-type="pmid">7959234</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodriguez-Bigas</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>O'Malley</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Weber</surname> <given-names>TK</given-names></name>, <name name-style="western"><surname>Suh</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>GR</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Establishment of a hereditary nonpolyposis colorectal cancer registry</article-title>. <source>Dis Colon Rectum</source> <volume>39</volume>: <fpage>649</fpage>–<lpage>653</lpage>. <object-id pub-id-type="pmid">8646951</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stella</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Surdo</surname> <given-names>NC</given-names></name>, <name name-style="western"><surname>Lastella</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Barana</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Oliani</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tibiletti</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC</article-title>. <source>Clin Genet</source> <volume>71</volume>: <fpage>130</fpage>–<lpage>139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1399-0004.2007.00745.x" xlink:type="simple">10.1111/j.1399-0004.2007.00745.x</ext-link></comment> <object-id pub-id-type="pmid">17250661</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ponti</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ruini</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tomasi</surname> <given-names>A</given-names></name> (<year>2015</year>) <article-title>Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?</article-title> <source>Dis Colon Rectum</source> <volume>58</volume>: <fpage>141</fpage>–<lpage>142</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/DCR.0000000000000275" xlink:type="simple">10.1097/DCR.0000000000000275</ext-link></comment> <object-id pub-id-type="pmid">25489705</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lagerstedt-Robinson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Rohlin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aravidis</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Melin</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Nordling</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stenmark-Askmalm</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2016</year>) <article-title>Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population</article-title>. <source>Oncol Rep</source> <volume>36</volume>: <fpage>2823</fpage>–<lpage>2835</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/or.2016.5060" xlink:type="simple">10.3892/or.2016.5060</ext-link></comment> <object-id pub-id-type="pmid">27601186</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ligtenberg</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Kuiper</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Chan</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Goossens</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hebeda</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Voorendt</surname> <given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1</article-title>. <source>Nat Genet</source> <volume>41</volume>: <fpage>112</fpage>–<lpage>117</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ng.283" xlink:type="simple">10.1038/ng.283</ext-link></comment> <object-id pub-id-type="pmid">19098912</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Litton</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Ready</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gutierrez-Barrera</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Etzel</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Meric-Bernstam</surname> <given-names>F</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Earlier age of onset of BRCA mutation-related cancers in subsequent generations</article-title>. <source>Cancer</source> <volume>118</volume>: <fpage>321</fpage>–<lpage>325</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.26284" xlink:type="simple">10.1002/cncr.26284</ext-link></comment> <object-id pub-id-type="pmid">21913181</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daugherty</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Pfeiffer</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Mellemkjaer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Hemminki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Goldin</surname> <given-names>LR</given-names></name> (<year>2005</year>) <article-title>No evidence for anticipation in lymphoproliferative tumors in population-based samples</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>14</volume>: <fpage>1245</fpage>–<lpage>1250</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1055-9965.EPI-04-0783" xlink:type="simple">10.1158/1055-9965.EPI-04-0783</ext-link></comment> <object-id pub-id-type="pmid">15894680</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref057"><label>57</label><mixed-citation publication-type="book" xlink:type="simple"><collab>Team RC</collab> (<year>2014</year>) <chapter-title>R: A language and environment for statistical computing</chapter-title>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>.</mixed-citation></ref>
<ref id="pgen.1007012.ref058"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Therneau TM (2015) coxme: Mixed Effects Cox Models. pp. R package version 2.2–4.</mixed-citation></ref>
<ref id="pgen.1007012.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boonstra</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Mukherjee</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Nilbert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Moreno</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Gruber</surname> <given-names>SB</given-names></name> (<year>2011</year>) <article-title>Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome</article-title>. <source>Biometrics</source> <volume>67</volume>: <fpage>1627</fpage>–<lpage>1637</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1541-0420.2011.01607.x" xlink:type="simple">10.1111/j.1541-0420.2011.01607.x</ext-link></comment> <object-id pub-id-type="pmid">21627626</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Falster</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Nakken</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bergem-Ohr</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rodland</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Breivik</surname> <given-names>J</given-names></name> (<year>2010</year>) <article-title>Unstable DNA repair genes shaped by their own sequence modifying phenotypes</article-title>. <source>J Mol Evol</source> <volume>70</volume>: <fpage>266</fpage>–<lpage>274</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00239-010-9328-0" xlink:type="simple">10.1007/s00239-010-9328-0</ext-link></comment> <object-id pub-id-type="pmid">20213140</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Senter</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Clendenning</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sotamaa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hampel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Green</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Potter</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations</article-title>. <source>Gastroenterology</source> <volume>135</volume>: <fpage>419</fpage>–<lpage>428</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2008.04.026" xlink:type="simple">10.1053/j.gastro.2008.04.026</ext-link></comment> <object-id pub-id-type="pmid">18602922</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larson</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Stringer</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Stringer</surname> <given-names>JR</given-names></name> (<year>2004</year>) <article-title>Impact of mismatch repair deficiency on genomic stability in the maternal germline and during early embryonic development</article-title>. <source>Mutat Res</source> <volume>556</volume>: <fpage>45</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mrfmmm.2004.06.036" xlink:type="simple">10.1016/j.mrfmmm.2004.06.036</ext-link></comment> <object-id pub-id-type="pmid">15491631</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>G-M</given-names></name> (<year>2008</year>) <article-title>Mechanisms and functions of DNA mismatch repair</article-title>. <source>Cell Res</source> <volume>18</volume>: <fpage>85</fpage>–<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cr.2007.115" xlink:type="simple">10.1038/cr.2007.115</ext-link></comment> <object-id pub-id-type="pmid">18157157</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mendez-Bermudez</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Royle</surname> <given-names>NJ</given-names></name> (<year>2011</year>) <article-title>Deficiency in DNA mismatch repair increases the rate of telomere shortening in normal human cells</article-title>. <source>Hum Mutat</source> <volume>32</volume>: <fpage>939</fpage>–<lpage>946</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.21522" xlink:type="simple">10.1002/humu.21522</ext-link></comment> <object-id pub-id-type="pmid">21538690</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bozzao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Lastella</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ponz de Leon</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pedroni</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Di Gregorio</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>D'Ovidio</surname> <given-names>FD</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome</article-title>. <source>Cancer</source> <volume>117</volume>: <fpage>4325</fpage>–<lpage>4335</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.26022" xlink:type="simple">10.1002/cncr.26022</ext-link></comment> <object-id pub-id-type="pmid">21387278</object-id></mixed-citation></ref>
<ref id="pgen.1007012.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Segui</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Pineda</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Guino</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Borras</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Navarro</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bellido</surname> <given-names>F</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Telomere length and genetic anticipation in Lynch syndrome</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e61286</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0061286" xlink:type="simple">10.1371/journal.pone.0061286</ext-link></comment> <object-id pub-id-type="pmid">23637804</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>